What EBIC can offer to centers and investigators:

EBIC is dedicated to promoting research in brain injury in collaborating member centers and is happy to advise on and support research proposals. Proposals from pharmaceutical companies are carefully evaluated by the Executive and studies with the best potential endorsed. EBIC sites with a good potential for participating and specific research proposals are nominated to the sponsor. In this way EBIC strives to promote high quality research in brain injury.

The consortium should have a major input in:

• The development of a coherent set of trial protocols covering the various therapeutic options under development. They should be optimal in terms of clinical relevance, data collection, reliability and independent statistical analysis.

• The choice of agents that are potentially most beneficial clinically.

• The design of case record forms.

• The development of a standardized set of core data over all consortium trials (which should be compatible with that being developed by the American Brain Injury Consortium).

• The establishment of criteria for outcome assessment.

• Independent statistical analysis.

• Rigorous interpretation and publication of results.